This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Radionics, Inc., Sherwood Services Ag, Covidien Ag. Active years: 1995-2009.
Location History:
- 1077 VG Amsterdam, NL (1995)
- VG Amsterdam, NL (1996)
- Lucerne, CH (2008)
- Amsterdam, NL (1999 - 2009)
Company Filing History:
3 out of 18 
2 out of 268 
1 out of 449 
Years Active: 1995-2009
Title: Menno E Sluijter: Innovator in Neural Tissue Modification
Introduction
Menno E Sluijter is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of neural tissue modification, holding a total of 8 patents. His innovative work focuses on methods and apparatuses that alter the function of neural tissue, providing new avenues for pain reduction in patients.
Latest Patents
Among his latest patents are two notable inventions: the "Method and Apparatus for Altering Neural Tissue Function" and the "Method and System for Neural Tissue Modification." Both patents describe a technique where an electromagnetic signal is applied to neural tissue through an electrode. This signal has a frequency component above the physiological stimulation frequency range and an intensity sufficient to produce an alteration in the neural tissue. The result is a reduction in pain for the patient, while the waveform used prevents lethal temperature elevation during the application of the electromagnetic signal.
Career Highlights
Menno has worked with several companies throughout his career, including Radionics, Inc. and Sherwood Services AG. His experience in these organizations has contributed to his expertise in the field of neural tissue modification.
Collaborations
Some of his notable coworkers include Eric R Cosman, Sr. and William J Rittman, III. Their collaboration has likely played a role in advancing the research and development of innovative solutions in neural tissue function.
Conclusion
Menno E Sluijter's work in neural tissue modification represents a significant advancement in medical technology. His patents and collaborations highlight his commitment to improving patient outcomes through innovative solutions.